PRESS DIGEST- New York Times business news - May 23
May 23 The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.
LONDON Europe's drug regulator has confirmed it is suspending marketing authorizations for Merck & Co's cholesterol drug Tredaptive in Europe after its failure in a major study raised safety concerns.
Merck began recalling the drug, which is also sold under the brand names Pelzont and Trevaclyn, on January 11 and recommended that doctors stop prescribing it.
The medicine had been on the market in 40 countries worldwide, but is not approved in the United States.
The European Medicines Agency said patients currently taking the drug should see their doctor to discuss their treatment.
(Reporting by Kate Kelland; Editing by Hans-Juergen Peters)
The following company announcements, scheduled economic indicators, debt and currency market moves and political events may affect African markets on Tuesday. - - - - - GLOBAL MARKETS Sterling extended losses on Tuesday after a suspected terrorist attack killed at least 19 people and wounded 50 at a pop concert in the English city of Manchester, while the euro held gains made after German Chancellor Angela Merkel said the currency was "too weak". WORLD OIL P
HONG KONG, May 23 Hong Kong police on Tuesday arrested 21 Uber drivers for illegal car-hiring as part of an ongoing clamp down against Uber Technologies Inc's operations in the Asian financial city.